XML 17 R2.htm IDEA: XBRL DOCUMENT v3.25.1
CONSOLIDATED BALANCE SHEET - USD ($)
$ in Millions
Mar. 31, 2025
Dec. 31, 2024
Investments:    
Fixed maturities, available for sale, at fair value (net of allowance for credit losses: March 31, 2025 - $38.9 and December 31, 2024 - $37.1; amortized cost: March 31, 2025 - $25,471.1 and December 31, 2024 - $25,264.3) $ 23,283.0 $ 22,840.5
Equity securities at fair value 349.1 162.0
Mortgage loans (net of allowance for credit losses: March 31, 2025 - $20.1 and December 31, 2024 - $13.6) 2,601.2 2,506.3
Policy loans 136.4 135.3
Trading securities 308.0 304.2
Investments held by variable interest entities (net of allowance for credit losses: March 31, 2025 - $2.5 and December 31, 2024 - $1.3; amortized cost: March 31, 2025 - $387.1 and December 31, 2024 - $437.0) 380.2 432.3
Other invested assets 1,386.7 1,491.5
Total investments 28,444.6 27,872.1
Cash and cash equivalents - unrestricted 928.2 1,656.7
Cash and cash equivalents held by variable interest entities 96.6 341.0
Accrued investment income 289.6 286.4
Present value of future profits 156.5 161.0
Deferred acquisition costs 2,209.9 2,158.6
Reinsurance receivables (net of allowance for credit losses: March 31, 2025 - $3.0 and December 31, 2024 - $3.0) 3,804.3 3,854.7
Income tax assets, net 775.1 818.9
Assets held in separate accounts 3.1 3.3
Other assets 728.4 699.9
Total assets 37,436.3 37,852.6
Liabilities for insurance products:    
Policyholder account balances 17,346.0 17,615.8
Future policy benefits 11,773.0 11,705.5
Market risk benefit liability 73.6 60.0
Liability for life insurance policy claims 63.5 61.1
Unearned and advanced premiums 221.5 226.8
Liabilities related to separate accounts 3.1 3.3
Other liabilities 1,027.2 1,161.8
Investment borrowings 2,188.6 2,188.8
Borrowings related to variable interest entities 375.1 497.6
Notes payable – direct corporate obligations 1,834.2 1,833.5
Total liabilities 34,905.8 35,354.2
Commitments and Contingencies (Note 13)
Shareholders' equity:    
Common stock ($0.01 par value, 8,000,000,000 shares authorized, shares issued and outstanding: March 31, 2025 – 99,893,923; December 31, 2024 – 101,618,957) 1.0 1.0
Additional paid-in capital 1,535.0 1,632.5
Accumulated other comprehensive loss (1,239.1) (1,371.4)
Retained earnings 2,233.6 2,236.3
Total shareholders' equity 2,530.5 2,498.4
Total liabilities and shareholders' equity $ 37,436.3 $ 37,852.6